Eiger Biopharmaceuticals, Inc.
EIGR
Revenue
3.21M
▼-1.43M▼-30.89%
3 Months ChangeAssets
38.83M
▼-16.83M▼-30.24%
3 Months ChangeLiabilities
53.28M
▼-3.97M▼-6.94%
3 Months ChangeFree Cash Flow
-24.22M
▼-5.76M▼-31.22%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-07-01
Form 8-K
ID: 0001193125-24-172678
2024-06-21
Form 8-K
ID: 0001193125-24-165736
2024-06-14
Form 8-K
ID: 0001193125-24-161203
2024-05-28
Form 8-K
ID: 0001193125-24-147523
2024-05-08
Form 8-K
ID: 0001193125-24-134319
2024-05-02
Form 8-K
ID: 0001193125-24-129415
2024-04-03
Form 8-K
ID: 0001193125-24-086059
2024-04-01
Form 8-K
ID: 0001193125-24-083403
2024-03-11
Form 8-K
ID: 0001193125-24-064785
2024-01-24
Form 8-K
ID: 0001193125-24-014312